Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Rifampicin
Drug ID BADD_D01936
Description A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
Indications and Usage Rifampin is an antibiotic that inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. It is bactericidal and has a very broad spectrum of activity against most gram-positive and gram-negative organisms (including Pseudomonas aeruginosa) and specifically Mycobacterium tuberculosis. Because of rapid emergence of resistant bacteria, use is restricted to treatment of mycobacterial infections and a few other indications. Rifampin is well absorbed when taken orally and is distributed widely in body tissues and fluids, including the CSF. It is metabolized in the liver and eliminated in bile and, to a much lesser extent, in urine, but dose adjustments are unnecessary with renal insufficiency.
Marketing Status Prescription
ATC Code J04AB02
DrugBank ID DB01045
KEGG ID D00211
MeSH ID D012293
PubChem ID 135398735
TTD Drug ID D0G3DL
NDC Product Code Not Available
Synonyms Rifampin | Benemycin | Rifampicin | Rimactan | Tubocin | Rifadin | Rimactane
Chemical Information
Molecular Formula C43H58N4O12
CAS Registry Number 13292-46-1
SMILES CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C) OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 3A4P08684T3784811316203; 9102699; 10447915
HepatotoxicityOmega-amidase NIT2Q9JHW2Not Available26004706
HepatotoxicityAlbuminP02770Not Available26004706
HepatotoxicityCatalaseP04762Not Available26004706
HepatotoxicityGlutathione peroxidase 1P04041Not Available26004706
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mycobacterium abscessus infection11.04.02.0040.012833%Not Available
Hyperlipasaemia14.11.01.0230.008555%Not Available
The 7th Page    First    Pre   7    Total 7 Pages